Starboard Wins More Board Seats, Replaces CEO at Depomed

Specialty pharmaceuticals maker Depomed has replaced its chief executive and named two new directors to its board after nearly a year of activist pressure from Starboard Value LP.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news
More News: Pharmaceuticals